Artelo Biosciences
NASDAQ:ARTLArtelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
ITEX
OTCMKTS:ITEXITEX Corporation operates a marketplace in which products and services are exchanged by marketplace members without exchanging cash in the United States. The company's marketplace provides a forum for members to purchase from and sell their products and services to other members using ITEX dollars instead of United States dollars. It also administers the marketplace, as well as provides record-keeping and payment transaction processing services. In addition, the company services its member businesses through its independent licensed brokers and franchise network. ITEX Corporation was founded in 1982 and is headquartered in Bellevue, Washington.
Janel
OTCMKTS:JANLJanel Corporation, through its subsidiaries, provides logistics services worldwide. It operates through three segments: Logistics, Life Sciences, and Manufacturing. The Logistics segment provides cargo transportation logistics management services, including freight forwarding by air, ocean, and land-based carriers; customs brokerage services; warehousing and distribution services; and other value added logistic services, as well as customs entry filing, cargo insurance procurement, logistics planning, product repackaging, and online shipment tracking services. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immuno-reagents for biomedical research; provides antibody manufacturing for academic and industry research scientists; and produces products for other life science companies on an original equipment manufacturer basis. The Manufacturing segment manufactures and distributes mixing equipment and apparatus for various industries, such as chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. The company was formerly known as Janel World Trade Ltd. and changed its name to Janel Corporation in April 2015. Janel Corporation was founded in 1974 and is headquartered in New York, New York.
SITO Mobile
NASDAQ:SITOSITO Mobile Ltd. engages in the provision of advertising solutions to businesses, advertisers, and brands. It offers Location Based Advertising, which display advertisements and videos on behalf of advertisers; and Mobile Messaging, a platform for building and controlling tailored programs including messaging and customer incentive programs. The company was founded by Anthony G. Macaluso on May 31, 2000 and is headquartered in Jersey City, NJ.